Page last updated: 2024-10-22

beta-aminoethyl isothiourea and Lymphoma, Non-Hodgkin

beta-aminoethyl isothiourea has been researched along with Lymphoma, Non-Hodgkin in 2 studies

beta-Aminoethyl Isothiourea: A radiation-protective agent that can inhibit DNA damage by binding to the DNA. It also increases the susceptibility of blood cells to complement-mediated lysis.

Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ALTENBRUNN, HJ2
HUBER, R1

Other Studies

2 other studies available for beta-aminoethyl isothiourea and Lymphoma, Non-Hodgkin

ArticleYear
[THE INFLUENCE OF CYSTEAMINE AND AET ON OXIDATIVE PHOSPHORYLATION OF IRRADIATED LYMPHOSARCOMA IN AN ASCITIC FORM].
    Radiobiologia, radiotherapia, 1964, Volume: 5

    Topics: beta-Aminoethyl Isothiourea; Cysteamine; Lymphoma, Non-Hodgkin; Metabolism; Mice; Mitochondria; Neop

1964
EXPERIMENTS ON INFLUENCEING THE RADIO-SENSITIVITY OF ANIMAL TUMOURS BY SH-COMPOUNDS.
    Acta - Unio Internationalis Contra Cancrum, 1964, Volume: 20

    Topics: beta-Aminoethyl Isothiourea; Carcinoma; Carcinoma 256, Walker; Cytochromes; Lymphoma; Lymphoma, Non-

1964